Ketamine infusion maximum dosage in acute liver failure
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Based on the textbook evidence gathered, here is a comprehensive answer:
Ketamine Infusion in Acute Liver Failure
Key Pharmacokinetic Concern
Ketamine is extensively hepatically metabolized — primarily by CYP3A4 (and to a lesser extent CYP2B6) — to its active metabolite norketamine (which retains 20–30% the activity of racemic ketamine). Its hepatic extraction ratio is approximately 0.9, meaning the liver clears nearly all of a dose on first pass. In acute liver failure (ALF), this metabolism is profoundly impaired, causing:
- Prolonged elimination half-life (normally ~2 hours)
- Accumulation of both ketamine and norketamine
- Unpredictable and extended duration of effect
— Morgan and Mikhail's Clinical Anesthesiology, 7e; Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e
Is Ketamine Contraindicated in Hepatic Disease?
Yes — ketamine should be avoided in patients with cardiovascular or hepatic disease, including acute liver failure. Standard perioperative guidelines list hepatic disease as a contraindication to ketamine infusion.
"Avoid in patients with psychiatric disturbance, cardiovascular or hepatic disease and in pregnancy." — Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e (Table 55-7 Intraoperative Multimodal Analgesia)
Additionally, repeated or prolonged ketamine administration is itself hepatotoxic — hepatotoxicity has been documented in patients receiving two 100-hour infusions of S(+)-ketamine for chronic pain, and is associated with recreational ketamine abuse.
— Miller's Anesthesia, 10e
Standard Dosing (For Reference — in Normal Hepatic Function)
| Route | Dose |
|---|---|
| Induction bolus (anesthesia) | 1–2 mg/kg IV |
| Sub-dissociative analgesia bolus | 0.1–0.35 mg/kg IV |
| Analgesic infusion | 0.1–1 mg/kg/hr IV |
| Status epilepticus loading dose | 1.5 mg/kg IV |
— Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e; Rosen's Emergency Medicine
In Acute Liver Failure: Practical Guidance
There is no validated maximum dose protocol for ketamine infusion specifically in ALF in the major textbooks — this is because its use is discouraged in this setting. If ketamine must be used (e.g., refractory status epilepticus, emergent airway with no alternatives):
- Use the lowest effective dose — start at the low end of the sub-dissociative range (≤0.1 mg/kg IV bolus)
- Expect markedly prolonged effect — titrate slowly and extend dosing intervals
- Avoid continuous infusions — accumulation risk is high
- Monitor for hepatotoxic effect — serial LFTs if repeated doses are required
- Consider alternatives — dexmedetomidine or propofol (with caution for propofol infusion syndrome) may be preferable for sedation in ALF, though all agents require dose reduction
Bottom Line
There is no established "maximum dose" for ketamine infusion in ALF — instead, the guidance is to avoid it. If used in exceptional circumstances, dose significantly below standard ranges, anticipate prolonged half-life due to impaired hepatic clearance, and monitor closely for accumulation and additional hepatotoxicity.
This is a shared conversation. Sign in to Orris to start your own chat.